Ion Channel Trafficking
The direct block of IKr by non-antiarrhythmic drugs is a major cause of QT prolongation and torsades de pointes (TdP), and has made the hERG potassium channel a major target of drug safety programs in cardiotoxicity.
Cambridge Bioscience, through our collaboration with ChanTest, offers a range of ion channel trafficking assays. ChanTest has developed highly predictive, rapid assays for the detection of cardiac ion channel trafficking inhibition for safety and drug discovery.
World’s Leading Ion Channel Service Provider
ChanTest have repeatedly been recognised as the "Most Trusted Fee-For-Service" & "Most Used Fee-For-Service" ion channel service provider. HTStec Ion Channel Trends Survey 2012
Request A No Obligation Quote
To find out more about the ion channel trafficking services offered, please click on the appropriate link below. Otherwise please contact our experienced team directly to discuss a ion channel trafficking project by Clicking Here